The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific
AbstractDespite huge efforts by academia and pharmaceutical industry, cancer remains the second cause of disease-related death in developed countries. Novel sources and principles of anticancer drug discovery are in urgent demand. Marine-derived natural products represent a largely untapped source of future drug candidates. This review focuses on the anticancer drug discovery potential of marine invertebrates from the North-West Pacific. The issues of biodiversity, chemodiversity, and the anticancer pharmacophore diversity this region hides are consecutively discussed. These three levels of diversity are analyzed from the point of view of the already discovered compounds, as well as from the assessment of the overall, still undiscovered and enormous potential. We further go into the predictions of the economic and societal benefits the full-scale exploration of this potential offers, and suggest strategic measures to be taken on the national level in order to unleash such full-scale exploration. The transversal and multi-discipline approach we attempt to build for the case of marine invertebrate-based anticancer drug discovery from a given region can be applied to other regions and disease conditions, as well as up-scaled to global dimensions. View Full-Text
Share & Cite This Article
Katanaev, V.L.; Di Falco, S.; Khotimchenko, Y. The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific. Mar. Drugs 2019, 17, 474.
Katanaev VL, Di Falco S, Khotimchenko Y. The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific. Marine Drugs. 2019; 17(8):474.Chicago/Turabian Style
Katanaev, Vladimir L.; Di Falco, Salvatore; Khotimchenko, Yuri. 2019. "The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific." Mar. Drugs 17, no. 8: 474.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.